Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
12/2003
12/16/2003US6663840 Process for treating dioxin-containing exhaust gas and composite catalyst composition for inhibiting generation of dioxin
12/11/2003WO2003102536A2 Destructible surfactants and uses thereof
12/11/2003WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
12/10/2003EP1368334A2 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues
12/10/2003EP1280790B1 Use of cyclic ketals as a fragrance
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/09/2003US6660890 Production of optically active α-hydroxyacetals
12/09/2003US6660860 Process for the selective oxidation of alcohols using readily removable nitroxyl radicals
12/09/2003US6660756 Protease inhibitors; sexual disorders
12/09/2003US6660677 Supported group 8-10 transition metal olefin polymerization catalysts
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group)
12/04/2003US20030225080 Treating a disorder responsive to the blockade of sodium channels
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors
12/03/2003EP1366037A2 Glycolide production process, and glycolic acid composition
12/03/2003CN1460107A Fluorinated and alkylated alditol derivatives and polyolefin articles containing same
12/02/2003US6657069 Reacting 6-aminocarbonylmethyl-4H-2,3- dioxin-4-one compound with alcohol or water to produce 3-oxopentanedicarboxylic acid amide esters; decyclization
12/02/2003US6656943 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands
12/02/2003US6656869 Bidentate ligands bonded to nickel, palladium, cobalt, or iron, and optionally, one or more neutral Lewis acids
12/02/2003CA2249756C New indanol compounds, their preparation process and the pharmaceutical compositions containing them
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
11/2003
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003US20030220517 Dechlorination in the presence of boron trifluoride; chemical intermediates for the synthesis of insecticides
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220334 Bryostatins exhibit potent activity against a broad range of human cancer cell lines
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003DE10213787C1 Verfahren zum Minimieren der Konzentration an toxischen organischen Schadstoffen in Flugstäuben A method of minimizing the concentration of toxic organic pollutants in flue dusts
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1000046B1 Piperazine derivatives active on the lower urinary tract
11/26/2003CN1128802C Phenyl-substituted cyclic ketoenol and pesticide and herbicide
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003095439A1 Methods for manufacture of dihydro-furan-2-one derivatives
11/20/2003US20030216554 Liquid-crystalline compounds
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030213417 Process for minimizing the concentration of toxic organic pollutants in fly dusts
11/20/2003CA2484342A1 Methods for manufacture of dihydro-furan-2-one derivatives
11/19/2003EP1362853A1 Styrene derivatives and process for production thereof
11/19/2003EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device
11/19/2003EP1132373B1 New derivatives of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol
11/19/2003EP0945452B1 Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them, and gel compositions
11/19/2003CN1128146C Dibenzol-1,3-dioxo-cyclooctane-2-oximino carboxylate compound with herbicidal activity
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649227 Difluorovinyl compound, liquid crystal composition and liquid crystal display
11/13/2003WO2003093223A1 Biphenyl carboxamides
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/12/2003EP1361223A1 Method of manufacture of 1,3-oxathiolane nucleosides
11/12/2003EP1359890A2 Primary intermediates for oxidative coloration of hair
11/12/2003EP0880509B1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant-growth regulators
11/12/2003CN1127503C (R)-2[3-(2-N-phthalic amino ethyl)-4,5-dihydro-5-isoxazolyl] -acezolyl] -acetic acid and its synthesis
11/12/2003CN1127483C Tert-butyl (3R,5R)-3, 5-dihydroxy-7-N-phthaloylimino heptanonate and its synthesis and use thereof
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646132 Information recording medium and novel oxonol compound
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/06/2003WO2003091238A1 Process for producing lactide
11/06/2003WO2002070509A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003US20030208081 Carbocyclic ethers such as (Methyl-(3-(4-phenoxy-phenoxy)-3-phenyl-propyl)-amino)-acetic acid, used as neurotransmitter antagonists, for prophylaxis of psychological disorders
11/06/2003US20030208075 Process for making chiral 1,4-disubstituted piperazines
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207898 Sulfides such as N-(2-(((6- chloro-1,3-benzodioxol-5-yl)methyl )thio)phenyl)thiophene-2-carboxamide used for controlling metabolism of lipids and prophylaxis of diabetes, Alzheimers disease, atherosclerosis, dyslipidemia and genetic disorders
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003CN1453078A Toxic compound processing system and method
11/04/2003US6642439 Basidiomycete manganese peroxidase gene-transferred plant and a method for removing an environmental contaminant using the same
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6641871 Electrooptical display
10/2003
10/30/2003WO2003089424A1 6-membered cyclic carbonates
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/29/2003EP1357134A2 Catalyst compositions for the polymerization of olefins
10/29/2003EP1357119A1 Process for producing lactide and process for producing polylactic acid starting with fermented lactic acid
10/29/2003CN1452618A Method for purifying cyclic esters
10/29/2003CN1452617A Acid-sensitive compounds, preparation and uses thereof
10/29/2003CN1451659A Still recovery of D,L-lactide from D.L-lactide recrystallization residual liquid
10/28/2003US6639105 For inhibiting tumor cell growth
10/28/2003US6638979 Imidamide derivatives
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/23/2003WO2003087034A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
10/23/2003WO2003086673A1 Method and device for removing harmful substances
10/23/2003WO2003086288A2 Bicyclic amides
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003CA2481313A1 Bicyclic amides
10/22/2003EP1353899A1 A process for the preparation of iopamidol and the new intermediates therein
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 103